Latest News
Publications & Abstracts
PER-001, an Endothelin Antagonist, Increased Optic Nerve Head Blood Flow and Improved Visual Function and Structure in Patients with Glaucoma
Steven L. Mansberger, Mahdi Basha, James Paauw, Sevgi Gurkan, Heather Schmitt, Michelle Chen, and Phillip Lai
American Glaucoma Society Meeting, Washington DC
Pharmacodynamic response of optic nerve head (ONH) vasculature measured by OCT-angiography (OCTA) after administration of the endothelin receptor antagonist PER-001
Brad Fortune; Grant Cull; Crystal Jadach; Kristine Ly; Michaela Dunn; Dawn Jennings; Trinity Holthausen; Howard Lockwood; Stuart Keith Gardiner; Lin Wang; Jennifer Wilk; Juan Reynaud
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3496. doi:
Pharmacodynamic response of optic nerve head (ONH) tissue blood flow measured by laser speckle flowgraphy (LSFG) after administration of PER-001, an endothelin receptor antagonist
Grant Cull; Crystal Jadach; Juan Reynaud; Kristine Ly; Michaela Dunn; Dawn Jennings; Trinity Holthausen; Howard Lockwood; Stuart Keith Gardiner; Lin Wang; Jennifer Wilk; Brad Fortune
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 4029 – A0414. doi:
